|
|
Article: Biovail Appoints Lloyd Segal to Company's Board of Directors.
- Article from:
- Business Wire
- Article date:
- December 10, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that Canadian pharmaceutical industry veteran Lloyd M. Segal, Chief Executive Officer of Thallion Pharmaceuticals Inc. of Montreal, has been appointed to Biovail's Board of Directors.
Mr. Segal's appointment is effective immediately.
"We're delighted to welcome Lloyd Segal to Biovail's Board of Directors," said Dr. Douglas Squires, Interim Chairman of the Board and the Company's CEO. "Mr. Segal's appointment provides pharmaceutical industry expertise upon which both the Board, and the Company's management team, can draw as Biovail moves through the next phase of its development."
...